Literature DB >> 17471500

MicroRNA-223 is a key factor in osteoclast differentiation.

T Sugatani1, K A Hruska.   

Abstract

MicroRNAs (miRNAs) are a class of noncording RNAs that control gene expression by translational inhibition and messenger RNAs (mRNAs) degradation in plants and animals. Although miRNAs have been implicated in developmental and homeostatic events of vertebrates and invertebrates, the role of miRNAs in bone metabolism has not been explored. Here, we show that microRNA-223 (miR-223) is expressed in RAW264.7 cells, mouse osteoclast precursor cell lines, and plays a critical role in osteoclast differentiation. We constructed miR-223 short interfering RNA (siRNA) or precursor miR-223 (pre-miR-223) overexpression retroviral vectors, and established miR-223 knockdown by siRNA or pre-miR-223 overexpression in stably infected RAW264.7 cells. Tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells were observed in miR-223 knockdown cells as well as control cells. In contrast, pre-miR-223 overexpression completely blocked TRAP-positive multinucleated cell formation compared with control cells. Apoptotic cells were not observed in this study. Our results indicate that miR-223 plays an essential role during osteoclast differentiation, and miR-223 might be a viable therapeutic target for a range of bone metabolic disorders with excess osteoclast activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471500     DOI: 10.1002/jcb.21335

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  74 in total

1.  A microRNA expression signature of osteoclastogenesis.

Authors:  Toshifumi Sugatani; Jean Vacher; Keith A Hruska
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

Review 2.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

3.  miR-30 family members negatively regulate osteoblast differentiation.

Authors:  Tingting Wu; Haibo Zhou; Yongfeng Hong; Jing Li; Xinquan Jiang; Hui Huang
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

Review 4.  Regulation of cholesterol homeostasis.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

Review 5.  MicroRNAs as novel regulators of stem cell fate.

Authors:  Eunhyun Choi; Eunmi Choi; Ki-Chul Hwang
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

6.  Conditional Disruption of miR17~92 in Osteoclasts Led to Activation of Osteoclasts and Loss of Trabecular Bone In Part Through Suppression of the miR17-Mediated Downregulation of Protein-Tyrosine Phosphatase-oc in Mice.

Authors:  Kin-Hing William Lau; Virginia M Stiffel; Charles H Rundle; Mehran Amoui; Jordan Tapia; Tyler D White; Matilda H-C Sheng
Journal:  JBMR Plus       Date:  2017-08-01

7.  Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1.

Authors:  Jin Zhang; Qisheng Tu; Lynda F Bonewald; Xi He; Gary Stein; Jane Lian; Jake Chen
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

8.  Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production.

Authors:  M-C Lu; C-L Yu; H-C Chen; H-C Yu; H-B Huang; N-S Lai
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

9.  MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.

Authors:  Claudia Goettsch; Joshua D Hutcheson; Elena Aikawa
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

10.  Impaired micro-RNA pathways diminish osteoclast differentiation and function.

Authors:  Toshifumi Sugatani; Keith A Hruska
Journal:  J Biol Chem       Date:  2008-12-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.